المؤلفون: Barbara Eichhorst, Carsten U. Niemann, Arnon P. Kater, Moritz Fürstenau, Julia von Tresckow, Can Zhang, Sandra Robrecht, Michael Gregor, Gunnar Juliusson, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Vesa Lindström, Caspar da Cunha-Bang, Christof Schneider, Christian B. Poulsen, Thomas Illmer, Björn Schöttker, Thomas Nösslinger, Ann Janssens, Ilse Christiansen, Michael Baumann, Henrik Frederiksen, Marjolein van der Klift, Ulrich Jäger, Maria B.L. Leys, Mels Hoogendoorn, Kourosh Lotfi, Holger Hebart, Tobias Gaska, Harry Koene, Lisbeth Enggaard, Jereon Goede, Josien C. Regelink, Anouk Widmer, Florian Simon, Nisha De Silva, Anna-Maria Fink, Jasmin Bahlo, Kirsten Fischer, Clemens-Martin Wendtner, Karl A. Kreuzer, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Mark-David Levin, Marinus van Oers, Christian Geisler, Stephan Stilgenbauer, Michael Hallek

المصدر: Eichhorst, B, Niemann, C U, Kater, A P, Fürstenau, M, von Tresckow, J, Zhang, C, Robrecht, S, Gregor, M, Juliusson, G, Thornton, P, Staber, P B, Tadmor, T, Lindström, V, da Cunha-Bang, C, Schneider, C, Poulsen, C B, Illmer, T, Schöttker, B, Nösslinger, T, Janssens, A, Christiansen, I, Baumann, M, Frederiksen, H, van der Klift, M, Jäger, U, Leys, M B L, Hoogendoorn, M, Lotfi, K, Hebart, H, Gaska, T, Koene, H, Enggaard, L, Goede, J, Regelink, J C, Widmer, A, Simon, F, De Silva, N, Fink, A-M, Bahlo, J, Fischer, K, Wendtner, C-M, Kreuzer, K A, Ritgen, M, Brüggemann, M, Tausch, E, Levin, M-D, van Oers, M, Geisler, C, Stilgenbauer, S, Hallek, M, German CLL Study Group (GCLLSG), Haemato-Oncology Foundation for Adults in the Netherlands (HOVON), Nordic CLL Study Groups, Swiss Group for Clinical Cancer Research (SAKK), The Israeli CLL Association & Cancer Trials Ireland 2023, ' First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia ', The New England Journal of Medicine, vol. 388, no. 19, pp. 1739-1754 . https://doi.org/10.1056/NEJMoa2213093

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoplasm, Residual/diagnosis, General Medicine, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Hematology/Oncology, Antineoplastic Agents/administration & dosage, Cyclophosphamide/administration & dosage, Rituximab/administration & dosage, Bridged Bicyclo Compounds, Heterocyclic/administration & dosage, Antineoplastic Agents, Immunological/administration & dosage, Leukemia/Lymphoma, Humans, Bendamustine Hydrochloride/administration & dosage, Treatments in Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57065540dd32adf0cc1d031449d13807
https://vbn.aau.dk/da/publications/3cae35e7-c81b-42b3-8598-001ac74af83e

المؤلفون: Elias K. Mai, Stefanie Huhn, Kaya Miah, Alexandra M. Poos, Christof Scheid, Katja C. Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W. Blau, Mathias Hänel, Hans J. Salwender, Axel Benner, Marc S. Raab, Hartmut Goldschmidt, Niels Weinhold

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: Blood cancer journal. 13(1)

مصطلحات موضوعية: bone marrow, hematology, Immunology, Neoplasm, Residual/diagnosis, Cell Biology, Prognosis, Biochemistry, Treatment Outcome, oncology, Internal Medicine, Humans, Multiple Myeloma/diagnosis, Retrospective Studies, mass spectrometry, transplantation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53de796cc73c2b8631be9bc42e215f3e
https://pubmed.ncbi.nlm.nih.gov/36599831

المساهمون: Reinhold, Uwe., Tilgen, W. (Wolfgang), 1944-, International Symposium on Minimal Residual Disease in Melanoma (1st : 1999 : Homburg, Saarland, Germany)

مصطلحات موضوعية: Neoplasm, Residual -- therapy., Neoplasm, Residual -- diagnosis., Neoplasm Metastasis -- diagnosis., Melanoma -- complications., Melanoma., Metastasis., Congresses.

المؤلفون: Signe Modvig, Rasmus Wernersson, Nina Friesgaard Øbro, Lars Rønn Olsen, Claus Christensen, Susanne Rosthøj, Matilda Degn, Gitte Wullf Jürgensen, Hans O. Madsen, Birgitte Klug Albertsen, Peder Skov Wehner, Steen Rosthøj, Henrik Lilljebjörn, Thoas Fioretos, Kjeld Schmiegelow, Hanne Vibeke Marquart

المصدر: Modvig, S, Wernersson, R, Øbro, N F, Olsen, L R, Christensen, C, Rosthøj, S, Degn, M, Jürgensen, G W, Madsen, H O, Albertsen, B K, Wehner, P S, Rosthøj, S, Lilljebjörn, H, Fioretos, T, Schmiegelow, K & Marquart, H V 2022, ' High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion ', Molecular Oncology, vol. 16, no. 10, pp. 2015-2030 . https://doi.org/10.1002/1878-0261.13207

مصطلحات موضوعية: Cancer Research, Neoplasm, Residual, cell migration, Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis, Antigens, CD34, acute lymphoblastic leukemia, protein–protein interaction networks, Immunophenotyping, SDG 3 - Good Health and Well-being, Cell Movement, Recurrence, hemic and lymphatic diseases, Cell Movement/genetics, Genetics, Humans, Acute lymphoblastic leukaemia, Neoplasm, Residual/diagnosis, General Medicine, Induction Chemotherapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Flow Cytometry, Burkitt Lymphoma, immunophenotype, Protein-protein interaction networks, Oncology, Molecular Medicine, CD34, prognosis, Cell Adhesion Molecules/genetics, Cell Adhesion Molecules

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21877df754daf556034f2cda95a623c
https://pure.au.dk/portal/da/publications/high-cd34-surface-expression-in-bcpall-predicts-poor-induction-therapy-response-and-is-associated-with-altered-expression-of-genes-related-to-cell-migration-and-adhesion(6af156a7-6ad3-47c4-a972-f1b1401ad4a0).html

المؤلفون: Alexander Schmitz, Rasmus Froberg Brøndum, Hans Erik Johnsen, Ulf-Henrik Mellqvist, Anders Waage, Peter Gimsing, Davine Hofste op Bruinink, Vincent van der Velden, Bronno van der Holt, Markus Hansson, Niels Frost Andersen, Ulf Christian Frølund, Carsten Helleberg, Fredrik H. Schjesvold, Lucia Ahlberg, Nina Gulbrandsen, Bjorn Andreasson, Birgitta Lauri, Einar Haukas, Julie Støve Bødker, Anne Stidsholt Roug, Martin Bøgsted, Marianne T. Severinsen, Henrik Gregersen, Niels Abildgaard, Pieter Sonneveld, Karen Dybkær

المساهمون: Immunology, Hematology

المصدر: Schmitz, A, Brøndum, R F, Johnsen, H E, Mellqvist, U H, Waage, A, Gimsing, P, Op Bruinink, D H, van der Velden, V, van der Holt, B, Hansson, M, Andersen, N F, Frølund, U C, Helleberg, C, Schjesvold, F H, Ahlberg, L, Gulbrandsen, N, Andreasson, B, Lauri, B, Haukas, E, Bødker, J S, Roug, A S, Bøgsted, M, Severinsen, M T, Gregersen, H, Abildgaard, N, Sonneveld, P & Dybkær, K 2022, ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission-results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ', BMC Cancer, vol. 22, 147 . https://doi.org/10.1186/s12885-022-09184-1
Schmitz, A, Brøndum, R F, Johnsen, H E, Mellqvist, U-H, Waage, A, Gimsing, P, Op Bruinink, D H, van der Velden, V, van der Holt, B, Hansson, M, Andersen, N F, Frølund, U C, Helleberg, C, Schjesvold, F H, Ahlberg, L, Gulbrandsen, N, Andreasson, B, Lauri, B, Haukas, E, Bødker, J S, Roug, A S, Bøgsted, M, Severinsen, M T, Gregersen, H, Abildgaard, N, Sonneveld, P & Dybkær, K 2022, ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission-results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ', BMC Cancer, vol. 22, no. 1, 147 . https://doi.org/10.1186/s12885-022-09184-1
BMC Cancer
22:147
BMC Cancer, 22(1):147. BioMed Central Ltd.
Schmitz, A, Brøndum, R F, Johnsen, H E, Mellqvist, U H, Waage, A, Gimsing, P, op Bruinink, D H, van der Velden, V, van der Holt, B, Hansson, M, Andersen, N F, Frølund, U C, Helleberg, C, Schjesvold, F H, Ahlberg, L, Gulbrandsen, N, Andreasson, B, Lauri, B, Haukas, E, Bødker, J S, Roug, A S, Bøgsted, M, Severinsen, M T, Gregersen, H, Abildgaard, N, Sonneveld, P & Dybkær, K 2022, ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ', BMC Cancer, vol. 22, no. 1, 147 . https://doi.org/10.1186/s12885-022-09184-1
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)

مصطلحات موضوعية: Male, Adult, Cancer Research, Neoplasm, Residual, Adolescent, Multiple Myeloma/drug therapy, Scandinavian and Nordic Countries, Sensitivity and Specificity, Young Adult, SDG 3 - Good Health and Well-being, Multiple myeloma, Predictive Value of Tests, Genetics, Humans, Flow cytometry, Longitudinal Studies, RC254-282, Randomized Controlled Trials as Topic, Cancer och onkologi, Research, Minimal residual disease, Remission Induction, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Neoplasm, Residual/diagnosis, Middle Aged, Prognosis, Oncology, Withholding Treatment, Cancer and Oncology, Female, Flow Cytometry/statistics & numerical data

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f84edb622806ece93a583643b317aedf
https://pure.eur.nl/en/publications/f6fe18ea-230e-4492-a12b-592fc27d7a7a

المؤلفون: Klaus Pantel, Catherine Alix-Panabières

المساهمون: Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Pôle Biologie-Pathologie [CHRU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)

المصدر: Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology, Nature Publishing Group, 2019, 16 (7), pp.409-424. ⟨10.1038/s41571-019-0187-3⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Neoplasm, Residual, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Cell-Free Nucleic Acids/genetics, Neoplasm Residual/diagnosis, Neoplastic Cells, Circulating/pathology, Precision Medicine, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Neoplasm, In patient, Liquid biopsy, business.industry, Liquid Biopsy, Cancer, Neoplastic Cells, Circulating, Prognosis, Primary lesion, medicine.disease, Precision medicine, Minimal residual disease, 030104 developmental biology, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, 030220 oncology & carcinogenesis, business, Cell-Free Nucleic Acids

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8152abcae409d0e9098ef6ce5732c30
https://doi.org/10.1038/s41571-019-0187-3

المؤلفون: Warland, V., Jerusalem, Guy, Hustinx, Roland, Beguin, Yves, Silvestre, R. M., Fassotte, Marie-France, Foidart, Jacqueline, Fillet, Georges

المصدر: Revue Médicale de Liège, 57 (12), 779-84 (2002)

مصطلحات موضوعية: Fluorodeoxyglucose F18/diagnostic use, Gallium Radioisotopes/diagnostic use, Humans, Lymphoma, Non-Hodgkin/radiography/radionuclide imaging, Neoplasm, Residual/diagnosis, Radiopharmaceuticals/diagnostic use, Tomography, Emission-Computed, Treatment Outcome, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

Relation: urn:issn:0370-629X; urn:issn:2566-1566

URL الوصول: https://orbi.uliege.be/handle/2268/10042

المؤلفون: Toft-Petersen, Marie, Stidsholt Roug, Anne, Plesner, Trine, Ebbesen, Lene, Brown, Gordon D., Nederby, Line

المصدر: Toft-Petersen, M, Stidsholt Roug, A, Plesner, T, Ebbesen, L, Brown, G D & Nederby, L 2018, ' The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia ', Cytometry. Part B: Clinical Cytometry, vol. 94, no. 3, pp. 520-526 . https://doi.org/10.1002/cyto.b.21540
Toft-Petersen, M, Stidsholt Roug, A, Plesner, T, Ebbesen, L, Brown, G D & Nederby, L 2018, ' The CLEC12A receptor marks human basophils : Potential implications for minimal residual disease detection in acute myeloid leukemia ', Cytometry. Part B: Clinical Cytometry, vol. 94, no. 3, pp. 520-526 . https://doi.org/10.1002/cyto.b.21540

مصطلحات موضوعية: Basophils/metabolism, Dendritic Cells/metabolism, Neoplasm, Residual/diagnosis, Flow Cytometry/methods, Leukemia, Myeloid, Acute/diagnosis, hMICL, immunophenotyping, Biomarkers, Tumor/metabolism, Humans, basophils, CD371, Lectins, C-Type/metabolism, Receptors, Mitogen/metabolism, CLEC12A

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fb0f54389f461991dd2a22f1bbda6b7d
https://pure.au.dk/portal/da/publications/the-clec12a-receptor-marks-human-basophils(c501d4ba-cf84-4d4a-a386-e5773a1d8208).html

المؤلفون: U. Reinhold, W. Tilgen

نوع المادة: eBook.

الموضوعات: Melanoma, Metastasis, Neoplasm, Residual--diagnosis--Congresses, Melanoma--complications--Congresses, Neoplasm Metastasis--diagnosis--Congresses, Neoplasm, Residual--therapy--Congresses

تصنيفات: MEDICAL / Oncology / General, MEDICAL / Dermatology, MEDICAL / Research

المؤلفون: Johan Maertens, Leo F. Verdonck, Georgine E. de Greef, Wim L.J. van Putten, Okke de Weerdt, Bob Löwenberg, Rik A. Brooimans, Alexander N Snel, Nancy Boeckx, Marie-Christiane Vekemans, Peter C. Huijgens, Urs Schanz, Thomas Pabst, Angèle Kelder, Vincent H.J. van der Velden, Bart J. Biemond, Gert J. Ossenkoppele, Yvonne J M Oussoren, Yves Chalandon, Marie-Cecile Legdeur, Urs Hess, Mario Bargetzi, J. Slomp, Peter J. M. Valk, P. W. Wijermans, Michel van Gelder, Frank Preijers, Gerrit Jan Schuurhuis, Monique Terwijn, Jan W. Gratama, Mojca Jongen-Lavrecic, Angelika M. Dräger, Willemijn J Scholten, Jürgen Kuball, Carlos Graux, Jakob Passweg

المساهمون: Hematology, Immunology, Medical Oncology, University of Zurich, Schuurhuis, G J, AII - Amsterdam institute for Infection and Immunity, CCA -Cancer Center Amsterdam, Clinical Haematology, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - School for Oncology and Reproduction, Hematology laboratory, CCA - Innovative therapy

المصدر: Journal of Clinical Oncology, 31, pp. 3889-97
Journal of Clinical Oncology, 31(31), 3889-+. American Society of Clinical Oncology
Journal of clinical oncology, 31(31), 3889-+. American Society of Clinical Oncology
Journal of Clinical Oncology, Vol. 31, No 31 (2013) pp. 3889-97
Journal of Clinical Oncology, 31(31), 3889-3897. American Society of Clinical Oncology
Terwijn, M, van Putten, W L J, Kelder, A, van der Velden, V H J, Brooimans, R A, Pabst, T, Maertens, J, Boeckx, N, de Greef, G E, Valk, P J M, Preijers, F W M B, Huijgens, P C, Drager, A M, Schanz, U, Jongen-Lavrecic, M, Biemond, B J, Passweg, J R, van Gelder, M, Wijermans, P, Graux, C, Bargetzi, M, Legdeur, M C, Kuball, J, de Weerdt, O, Chalandon, Y, Hess, U, Verdonck, L F, Gratama, J W, Oussoren, Y J M, Scholten, W J, Slomp, J, Snel, A N, Vekemans, M C, Lowenberg, B, Ossenkoppele, G J & Schuurhuis, G J 2013, ' High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study ', Journal of Clinical Oncology, vol. 31, no. 31, pp. 3889-3897 . https://doi.org/10.1200/JCO.2012.45.9628
Journal of Clinical Oncology, 31, 3889-97
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

مصطلحات موضوعية: Oncology, Male, Cancer Research, Neoplasm, Residual, Myeloid, 0302 clinical medicine, hemic and lymphatic diseases, Granulocyte Colony-Stimulating Factor, 1306 Cancer Research, Granulocyte Colony-Stimulating Factor/administration & dosage, ddc:616, Remission Induction, Myeloid leukemia, Induction Chemotherapy, Middle Aged, Flow Cytometry, Prognosis, 3. Good health, Leukemia, Myeloid, Acute, Leukemia, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, 2730 Oncology, Sample collection, Adult, medicine.medical_specialty, Adolescent, Context (language use), 610 Medicine & health, Neoplasm Recurrence, Local/diagnosis, 03 medical and health sciences, Induction Chemotherapy/methods, Young Adult, SDG 3 - Good Health and Well-being, Translational research [ONCOL 3], Internal medicine, medicine, Consolidation Chemotherapy/methods, Humans, Proportional Hazards Models, Leukemia, Myeloid, Acute/diagnosis/drug therapy, business.industry, Induction chemotherapy, Neoplasm, Residual/diagnosis, medicine.disease, Minimal residual disease, Flow Cytometry/methods, Consolidation Chemotherapy, Clinical trial, body regions, Immunology, 10032 Clinic for Oncology and Hematology, Neoplasm Recurrence, Local, business, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63356c0276fa1f699e7f41ae70a62b68
https://hdl.handle.net/2066/185103